Skip to main navigation Skip to search Skip to main content

Oral varespladib for the treatment of snakebite envenoming in India and the USA (BRAVO): a phase II randomised clinical trial

  • Charles J. Gerardo
  • , Rebecca W. Carter
  • , Surendra Kumar
  • , Farshad M. Shirazi
  • , Suneetha D. Kotehal
  • , Peter D. Akpunonu
  • , Ashish Bhalla
  • , Richard B. Schwartz
  • , Chanaveerappa Bammigatti
  • , Neeraj Manikath
  • , Partha P. Mukherjee
  • , Thomas C. Arnold
  • , Brian J. Wolk
  • , Sophia S Sheikh
  • , Dawn R. Sollee
  • , David J. Vearrier
  • , Samuel J. Francis
  • , Adiel Aizenberg
  • , Harish Kumar
  • , Madhu K. Ravikumar
  • Sujoy Sarkar, Taylor Haston, Andrew Micciche, Suraj C. Oomman, Jeffery L. Owen, Brandi A. Ritter, Stephen P. Samuel, Matthew R. Lewin, Timothy F. Platts-Mills

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numbere015985
JournalBMJ Global Health
Volume9
Issue number10
DOIs
StatePublished - Oct 22 2024

ASJC Scopus Subject Areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Keywords

  • Neurology
  • Poisoning
  • Snake bite, stings and other evenoming
  • Snake Bites/drug therapy
  • Keto Acids/therapeutic use
  • Double-Blind Method
  • Antivenins/therapeutic use
  • United States
  • Benzoates/therapeutic use
  • Administration, Oral
  • Humans
  • Middle Aged
  • Male
  • Treatment Outcome
  • Acetates
  • India
  • Young Adult
  • Animals
  • Adolescent
  • Female
  • Adult
  • Indoles

Cite this